Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Technology Stocks & Market Talk With Don Wolanchuk -- Ignore unavailable to you. Want to Upgrade?

To: kapex who wrote (190409)	5/30/2023 9:25:41 AM
From: threedrives	6 Recommendations Recommended By Hugh Bett isopatch kapex roguedolphin vixson and 1 more member Respond to of 208235

Thanks all for quick response.... fever broke on ivermectin...

To: kapex who wrote (190409)	5/30/2023 4:44:42 PM
From: Winfastorlose	8 Recommendations Recommended By D.Austin easygoer Hugh Bett IC720 isopatch and 3 more members Read Replies (1) \| Respond to of 208235

Majority of COVID Hospital Deaths Were Due to Untreated Bacterial Pneumonia… Knowing that people who were symptomatic for respiratory infections would be among the most tested population and that Dr. Anthony Fauci’s medical approach to COVID-19 was to tell people to go home and get as sick as possible, it was readily clear that people would be dying due to lack of treatment for treatable conditions, like bacterial pneumonia and fungal infections in the lung. Now a study from the National Institutes of Health-funded researchers in Chicago has found that unresolved respiratory infections—not necessarily those involved in SARS-CoV-2—were present in people who failed to “respond” to mechanical ventilation. The authors wrote: “Recent data suggest that secondary pneumonia is present in up to 40% and pneumonia or diffuse alveolar damage is present in over 90% of autopsy specimens obtained from patients with acute SARS-CoV-2 infection (18). “Consistent with these observations, we and others found high rates of ventilator-associated pneumonia (VAP) in patients with SARS-CoV-2 pneumonia requiring mechanical ventilation, suggesting that bacterial superinfections such as VAP may contribute to mortality in patients with COVID-19 (7, 19–22). “These findings prompt an alternative hypothesis that a relatively low mortality rate directly attributable to primary SARS-CoV-2 infection is offset by a greater risk of death attributable to unresolving VAP (23).” They concluded: “These data suggest mortality associated with severe SARS-CoV-2 pneumonia is more often associated with respiratory failure that increases the risk of unresolving VAP and is less frequently associated with multiple-organ dysfunction.”